查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454116

顏面神經麻痺市場，按診斷、治療、最終用途、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Facial Palsy Market, By Diagnosis, By Treatment, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，顏面神經麻痺市場規模達 32.21 億美元，2024 年至 2032 年複合CAGR為 4.5%。

顏面神經麻痺市場-市場動態

顏面神經盛行率不斷上升推動市場需求

面癱的日益流行預計將推動預測期內的市場成長。例如，根據國家神經疾病和中風研究所的數據，貝爾麻痺是顏面神經麻痺最常見的原因。據估計，有 4 萬名美國人患有貝爾氏麻痺引起的顏面神經麻痺。中風相關的顏面神經麻痺會損害控制臉部肌肉的神經。中風會導致出血，並因缺氧而損害腦組織。其他面癱的原因包括梅爾克森-羅森塔爾症候群、格林-巴利症候群、莫比烏斯症候群、萊姆病和拉姆齊-亨特氏症候群。貝爾氏麻痺症患者的年齡更有可能在 15 歲至 60 歲之間。

顏面神經麻痺市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 4.5% 左右的CAGR成長

基於診斷細分，MRI 細分市場預計將在預測期內佔據重要的市場佔有率

根據治療細分，非手術細分市場在 2023 年佔據最大市場佔有率

根據最終用途細分，預計醫院細分市場將在預測期內引領市場

按地區分類，北美是 2023 年的主要收入來源

顏面神經麻痺市場-細分分析：

全球臉部麻痺市場根據診斷、治療、最終用途和地區進行細分。

根據診斷，市場分為 MRI、CT 和肌電圖 (EMG)。預計 MRI 細分市場將在預測期內佔據重要的市場佔有率。當顏面神經麻痺伴隨其他神經系統症狀（例如頭痛、頭暈或視力或聽力變化）時，MRI 可以幫助識別影響神經系統的任何潛在疾病。

根據治療方法，市場分為手術治療和非手術治療。非手術治療在 2023 年佔據最大的市場佔有率，預計在預測期內將繼續保持相同的格局。物理治療在顏面神經麻痺治療中發揮著至關重要的作用，重點是加強臉部肌肉、改善協調性和恢復活動範圍的練習和技術。通常採用臉部運動、按摩、電刺激和生物回饋等治療方式來促進復原。從而推動該細分市場的成長。

根據最終用途，該行業分為醫院和專科中心。由於大量患者和先進技術的存在，醫院部門預計將在預估期間內引領市場。

顏面神經麻痺市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計在預測期內，北美將引領顏面神經麻痺市場。北美各地都有完善的醫療保健設施，包括幫助治療顏面神經麻痺的專科診所和復健計劃，尤其是在美國和加拿大。由於醫療費用不斷成長、對罕見疾病的認知不斷提高以及醫療基礎設施的發展等因素，預計亞太地區的市場將大幅成長。研究機構、製藥企業和醫療保健組織的合作可能會在該領域創造出新穎的顏面神經麻痺療法。

顏面神經麻痺市場-競爭格局：

該市場的主要參與者包括波士頓科學公司、諾華公司、Cyber​​onics, Inc.、Astellas Pharma Inc.、Mallinckrodt、Cerebomed、BioControl Medical 和 Sucampo Pharmaceuticals。為了進入新市場，市場參與者不斷採取各種策略性舉措，包括創造新產品、融資和投資、併購以及其他策略夥伴關係。

最近的發展：

2023 年 7 月，Sakra 世界醫院開設了最先進的臉部麻痺護理中心，包括尖端技術和技術精湛的外科醫生團隊。透過將尖端技術與由外科醫生和其他醫療保健專業人員組成的熟練多學科團隊相結合，該中心力求轉變治療模式，改善整體治療效果，並顯著改善面癱患者的生活品質。

目錄

第1章：面癱市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 顏面神經麻痺市場診斷摘要
    • 顏面神經麻痺治療市場片段
    • 以最終用途分類的面癱市場片段
    • 按國家/地區分類的面癱市場片段
    • 按地區分類的顏面神經麻痺市場片段
  • 競爭洞察

第 3 章：面癱主要市場趨勢

  • 顏面神經麻痺市場促進因素
    • 市場促進因素的影響分析
  • 顏面神經麻痺市場限制
    • 市場限制影響分析
  • 顏面神經麻痺市場機會
  • 顏面神經麻痺市場未來趨勢

第 4 章：面癱產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：顏面神經麻痺市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：面癱市場格局

  • 2023 年面癱市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：顏面神經麻痺市場 - 透過診斷

  • 概述
    • 透過診斷進行細分市場佔有率分析
    • 核磁共振成像
    • CT
    • 肌電圖（EMG）

第 8 章：顏面神經麻痺市場 - 依治療分類

  • 概述
    • 按處理方式分類的細分市場佔有率分析
    • 外科
    • 非手術

第 9 章：顏面神經麻痺市場 - 依最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 專科中心

第 10 章：顏面神經麻痺市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美顏面神經麻痺主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按診斷）
    • 北美市場規模與預測（以不同處理方式）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲顏面神經麻痺主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（透過診斷）
    • 歐洲市場規模與預測（按處理方式）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區面癱主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模及預測（依診斷）
    • 亞太地區市場規模與預測（以不同處理方式）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲顏面神經麻痺主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按診斷）
    • 拉丁美洲市場規模與預測（以不同處理方式）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲顏面神經麻痺主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按診斷）
    • 中東及非洲市場規模及預測（依不同處理方式）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 顏面神經麻痺產業

  • 競爭儀表板
  • 公司簡介
    • Boston Scientific Corporation
    • Novartis AG
    • Cyberonics, Inc.
    • Astellas Pharma Inc.
    • Mallinckrodt
    • Cerebomed
    • BioControl Medical
    • Sucampo Pharmaceuticals

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2297

REPORT HIGHLIGHT

Facial Palsy Market size was valued at USD 3,221 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Facial palsy is a broad term for paralysis of the face muscles, primarily due to acute or chronic injury to the face nerve. The facial muscles cannot contract correctly if a facial nerve is absent or non-functioning. This is because the muscles need to receive impulses in order to contract. This causes the afflicted facial area to become paralyzed, which can impair mobility in other regions of the face as well as the affected eye or mouth.

Facial Palsy Market- Market Dynamics

Growing prevalence of facial paralysis to propel market demand

The growing prevalence of facial paralysis is expected to propel the market growth during the forecast period. For instance, Bell's palsy is the most prevalent cause of facial paralysis, according to the National Institute of Neurological Disorders and Stroke. An estimated 40,000 Americans are thought to suffer from facial paralysis brought on by Bell's palsy. Stroke-related facial paralysis damages the nerves that govern the face muscles. Stoke results in bleeding and damages brain tissue by depriving it of oxygen. Additional causes of facial paralysis include Melkersson-Rosenthal syndrome, Guillain-Barre syndrome, Mobius syndrome, Lyme illness, and Ramsay-Hunt syndrome. People with Bell's palsy are more likely to be between the ages of 15 and 60.

Facial Palsy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on diagnosis segmentation, the MRI segment is expected to capture a significant market share during the forecast period

Based on the treatment segmentation, the non-surgical segment held the largest market share in 2023

Based on end-use segmentation, the hospitals segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Facial Palsy Market- Segmentation Analysis:

The Global Facial Palsy Market is segmented based on Diagnosis, Treatment, End-use, and Region.

Based on the diagnosis, the market is categorized into MRI, CT and Electromyograph (EMG). The MRI segment is expected to capture a significant market share during the forecast period. When facial palsy is accompanied by other neurological symptoms, such as headaches, dizziness, or changes in vision or hearing, MRI can help identify any underlying conditions affecting the nervous system.

Based on the treatment, the market is divided into Surgical and Non-Surgical. The non-surgical held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. Physical therapy plays a crucial role in the management of facial palsy by focusing on exercises and techniques to strengthen facial muscles, improve coordination, and restore range of motion. Therapeutic modalities such as facial exercises, massage, electrical stimulation, and biofeedback are commonly employed to facilitate recovery. Thereby, driving the segment growth.

Based on the end-use, the industry is divided into Hospitals and Specialty Centers. The hospitals segment is expected to lead the market over the projected period owing to large pool of patients and the presence of advanced technologies.

Facial Palsy Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Facial Palsy market during the forecast period. Well-established healthcare facilities, including specialist clinics and rehabilitation programs that aid in the management of facial palsy, may be found across North America, but especially in the United States and Canada. Due to factors including growing healthcare expenses, growing awareness of rare diseases, and developing healthcare infrastructure, the market is anticipated to grow considerably in Asia Pacific. Research institutes, pharmaceutical businesses, and healthcare organizations working together might result in the creation of novel facial palsy therapies in the area.

Facial Palsy Market- Competitive Landscape:

The key players operating in the market are Boston Scientific Corporation, Novartis AG, Cyberonics, Inc., Astellas Pharma Inc., Mallinckrodt, Cerebomed, BioControl Medical and Sucampo Pharmaceuticals. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In July 2023, a state-of-the-art Facial Palsy Care Center including cutting-edge technology and a skilled group of exceptionally skilled surgeons was opened by Sakra World Hospital. By combining cutting-edge technology with a skilled multidisciplinary team of surgeons and other healthcare professionals, the center sought to transform treatment models, improve overall therapeutic results, and significantly improve the quality of life for those with facial palsy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FACIAL PALSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Boston Scientific Corporation

Novartis AG

Cyberonics, Inc.

Astellas Pharma Inc.

Mallinckrodt

Cerebomed

BioControl Medical

Sucampo Pharmaceuticals

GLOBAL FACIAL PALSY MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • MRI
  • CT
  • Electromyograph (EMG)

GLOBAL FACIAL PALSY MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Surgical
  • Non-Surgical

GLOBAL FACIAL PALSY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Centers

GLOBAL FACIAL PALSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Facial Palsy Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Facial Palsy Market Snippet by Diagnosis
    • 2.1.2.Facial Palsy Market Snippet by Treatment
    • 2.1.3.Facial Palsy Market Snippet by End-use
    • 2.1.4.Facial Palsy Market Snippet by Country
    • 2.1.5.Facial Palsy Market Snippet by Region
  • 2.2.Competitive Insights

3.Facial Palsy Key Market Trends

  • 3.1.Facial Palsy Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Facial Palsy Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Facial Palsy Market Opportunities
  • 3.4.Facial Palsy Market Future Trends

4.Facial Palsy Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Facial Palsy Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Facial Palsy Market Landscape

  • 6.1.Facial Palsy Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Facial Palsy Market - By Diagnosis

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2.MRI
    • 7.1.3.CT
    • 7.1.4.Electromyograph (EMG)

8.Facial Palsy Market - By Treatment

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 8.1.2.Surgical
    • 8.1.3.Non-Surgical

9.Facial Palsy Market - By End-use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Specialty Centers

10.Facial Palsy Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Facial Palsy Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Facial Palsy Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Facial Palsy Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Facial Palsy Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Facial Palsy Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Facial Palsy Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Boston Scientific Corporation
    • 11.2.2.Novartis AG
    • 11.2.3.Cyberonics, Inc.
    • 11.2.4.Astellas Pharma Inc.
    • 11.2.5.Mallinckrodt
    • 11.2.6.Cerebomed
    • 11.2.7.BioControl Medical
    • 11.2.8.Sucampo Pharmaceuticals

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Facial Palsy Market: Diagnosis Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnosis
  • TABLE Global Facial Palsy Market, by Diagnosis 2019-2032 (USD Million)
  • TABLE Facial Palsy Market: Treatment Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Facial Palsy Market, by Treatment 2019-2032 (USD Million)
  • TABLE Facial Palsy Market: End-useSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Facial Palsy Market, by End-use2019-2032 (USD Million)
  • TABLE Facial Palsy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Facial Palsy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Facial Palsy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Facial Palsy Market, by Diagnosis, 2019-2032 (USD Million)
  • TABLE North America Facial Palsy Market, by Treatment, 2019-2032 (USD Million)
  • TABLE North America Facial Palsy Market, by End-use, 2019-2032 (USD Million)
  • TABLE Europe Facial Palsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Facial Palsy Market, by Diagnosis, 2019-2032 (USD Million)
  • TABLE Europe Facial Palsy Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Europe Facial Palsy Market, by End-use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Facial Palsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Facial Palsy Market, by Diagnosis, 2019-2032 (USD Million)
  • TABLE Asia Pacific Facial Palsy Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Asia Pacific Facial Palsy Market, by End-use, 2019-2032 (USD Million)
  • TABLE Latin America Facial Palsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Facial Palsy Market, by Diagnosis, 2019-2032 (USD Million)
  • TABLE Latin America Facial Palsy Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Latin America Facial Palsy Market, by End-use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Facial Palsy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Facial Palsy Market, by Diagnosis, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Facial Palsy Market, by Treatment, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Facial Palsy Market, by End-use, 2019-2032 (USD Million)